Comparing two insulin infusion protocols for diabetic patients in ICU
Comparing Glycemic Control Efficacy Between The National Health System and Suez Canal University Protocols of Intravenous Insulin Infusion for Diabetic Adults in ICU
This study is testing two different insulin delivery methods to see which one helps critically ill diabetic patients in the ICU better control their blood sugar levels.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Suez Canal University Academic / other |
| Locations | 1 site (Ismailia) |
| Trial ID | NCT06810596 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to improve blood sugar control in critically ill diabetic adults admitted to the ICU by comparing the efficacy of two intravenous insulin infusion protocols: one from the NHS in the UK and another developed by Suez Canal University (SCU). Patients will be randomly assigned to either the SCU or NHS protocol, with blood glucose levels monitored and managed according to the respective guidelines. The study will assess which protocol better achieves target glycemic control in this vulnerable patient population.
Who should consider this trial
Good fit: Ideal candidates are critically ill adult patients with diabetes and an HbA1C greater than 6.0.
Not a fit: Patients with diabetic ketoacidosis, pregnant or breastfeeding individuals, and those with hyperosmolar non-ketotic coma may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved blood glucose management in critically ill diabetic patients, potentially reducing complications and improving outcomes.
How similar studies have performed: Other studies have shown varying success with different insulin infusion protocols, but this specific comparison is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who admitted to the hospital with a potentially life-threatening condition (Critically ill patients) with HbA1C \>6.0. Exclusion Criteria: * DKA patients. * Pregnant or breast-feeding patients. * Hyperosmolar Non-Ketotic Coma.
Where this trial is running
Ismailia
- Suez Canal University Hospitals — Ismailia, Egypt (Recruiting)
Study contacts
- Study coordinator: Aiman A. Al-Touny, MD
- Email: Aimantouny@med.suez.edu.eg
- Phone: +201008185785
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.